Declining health in the oldest-old takes an energy toll for the simple maintenance of body functions. The underlying mechanisms, however, differ in males and females. In females, the declines are explained by loss of muscle mass; but this is not the case in males, in whom they are associated with increased levels of circulating creatine kinase. This relationship raises the possibility that muscle damage rather than muscle loss is the cause of the increased energy demands of unhealthy aging in males. We have now examined factors that contribute to the increase in creatine kinase. Much of it (60%) can be explained by a history of cardiac problems and lower kidney function, while being mitigated by moderate physical activity, reinforcing the notion that tissue damage is a likely source. In a search for genetic risk factors associated with elevated creatine kinase, the Ku70 gene XRCC6 and the ceramide synthase gene LASS1 were investigated because of their roles in telomere length and longevity and healthy aging, respectively. Single nucleotide polymorphisms in these two genes were independently associated with creatine kinase levels. The XRCC6 variant was epistatic to one of the LASS1 variants but not to the other. These gene variants have potential regulatory activity. Ku70 is an inhibitor of the proapoptotic Bax, while the product of Lass1, ceramide, operates in both caspase-dependent and -independent pathways of programmed cell death, providing a potential cellular mechanism for the effects of these genes on tissue damage and circulating creatine kinase.

1.
Kim S, Welsh DA, Ravussin E, Welsch MA, Cherry KE, Myers L, Jazwinski SM: An elevation of resting metabolic rate with declining health in nonagenarians may be associated with decreased muscle mass and function in women and men, respectively. J Gerontol A Biol Sci Med Sci 2014;69:650-656.
[PubMed]
2.
Kim S, Welsh DA, Cherry KE, Myers L, Jazwinski SM: Association of healthy aging with parental longevity. Age (Dordr) 2013;35:1975-1982.
[PubMed]
3.
Apple FS, Rhodes M: Enzymatic estimation of skeletal muscle damage by analysis of changes in serum creatine kinase. J Appl Physiol 1988;65:2598-2600.
[PubMed]
4.
Hagisawa S, Ferguson-Pell MW, Palmieri VR, Cochran GV: Pressure sores: a biochemical test for early detection of tissue damage. Arch Phys Med Rehabil 1988;69:668-671.
[PubMed]
5.
Volfinger L, Lassourd V, Michaux JM, Braun JP, Toutain PL: Kinetic evaluation of muscle damage during exercise by calculation of amount of creatine kinase released. Am J Physiol 1994;266:R434-R441.
[PubMed]
6.
Wallimann T, Wyss M, Brdiczka D, Nicolay K, Eppenberger HM: Intracellular compartmentation, structure and function of creatine kinase isoenzymes in tissues with high and fluctuating energy demands: the ‘phosphocreatine circuit' for cellular energy homeostasis. Biochem J 1992;281:21-40.
[PubMed]
7.
Schlattner U, Tokarska-Schlattner M, Wallimann T: Mitochondrial creatine kinase in human health and disease. Biochim Biophys Acta 2006;1762:164-180.
[PubMed]
8.
Bessman SP, Geiger PJ: Transport of energy in muscle: the phosphorylcreatine shuttle. Science 1981;211:448-452.
[PubMed]
9.
Guimarães-Ferreira L: Role of the phosphocreatine system on energetic homeostasis in skeletal and cardiac muscles. Einstein (Sao Paulo) 2014;12:126-131.
[PubMed]
10.
Gasper MC, Gilchrist JM: Creatine kinase: a review of its use in the diagnosis of muscle disease. Med Health RI 2005;88:398, 400-404.
[PubMed]
11.
Silvestri NJ, Wolfe GI: Asymptomatic/pauci-symptomatic creatine kinase elevations (hyperCKemia). Muscle Nerve 2013;47:805-815.
[PubMed]
12.
Kodatsch I, Finsterer J, Stöllberger C: Serum creatine kinase elevation in a medical department. Acta Med Austriaca 2001;28:11-15.
[PubMed]
13.
Clarkson PM, Eichner ER: Exertional rhabdomyolysis: does elevated blood creatine kinase foretell renal failure? Curr Sports Med Rep 2006;5:57-60.
[PubMed]
14.
Ferrari M, Guasti L, Maresca A, Mirabile M, Contini S, Grandi AM, Marino F, Cosentino M: Association between statin-induced creatine kinase elevation and genetic polymorphisms in SLCO1B1, ABCB1 and ABCG2. Eur J Clin Pharmacol 2014;70:539-547.
[PubMed]
15.
Fukami M, Maeda N, Fukushige J, Kogure Y, Shimada Y, Ogawa T, Tsujita Y: Effects of HMG-CoA reductase inhibitors on skeletal muscles of rabbits. Res Exp Med (Berl) 1993;193:263-273.
[PubMed]
16.
Israeli A, Raveh D, Arnon R, Eisenberg S, Stein Y: Lovastatin and elevated creatine kinase: results of rechallenge. Lancet 1989;1:725.
[PubMed]
17.
Thompson PD, Nugent AM, Herbert PN: Increases in creatine kinase after exercise in patients treated with HMG Co-A reductase inhibitors. JAMA 1990;264:2992.
[PubMed]
18.
Hekimsoy Z, Oktem IK: Serum creatine kinase levels in overt and subclinical hypothyroidism. Endocr Res 2005;31:171-175.
[PubMed]
19.
Sudarsanan S, Omar AS, Pattath RA, Al Mulla A: Acute kidney injury associated with rhabdomyolysis after coronary artery bypass graft: a case report and review of the literatures. BMC Res Notes 2014;7:152.
[PubMed]
20.
Barbano B, Sardo L, Gasperini ML, Gigante A, Liberatori M, Giraldi GD, Di Mario F, Dorelli B, Amoroso A, Cianci R: Drugs and rhabdomyolysis: from liver to kidney. Curr Vasc Pharmacol 2015;13:725-737.
[PubMed]
21.
Chiong M, Wang ZV, Pedrozo Z, Cao DJ, Troncoso R, Ibacache M, Criollo A, Nemchenko A, Hill JA, Lavandero S: Cardiomyocyte death: mechanisms and translational implications. Cell Death Dis 2011;2:e244.
[PubMed]
22.
Kim NH, Kang PM: Apoptosis in cardiovascular diseases: mechanism and clinical implications. Korean Circ J 2010;40:299-305.
[PubMed]
23.
Takemura G, Fujiwara H: Role of apoptosis in remodeling after myocardial infarction. Pharmacol Ther 2004;104:1-16.
[PubMed]
24.
Takemura G, Kanoh M, Minatoguchi S, Fujiwara H: Cardiomyocyte apoptosis in the failing heart - a critical review from definition and classification of cell death. Int J Cardiol 2013;167:2373-2386.
[PubMed]
25.
van Empel VP, Bertrand AT, Hofstra L, Crijns HJ, Doevendans PA, De Windt LJ: Myocyte apoptosis in heart failure. Cardiovasc Res 2005;67:21-29.
[PubMed]
26.
Wang X, Parrish AR: Loss of α(E)-catenin promotes Fas mediated apoptosis in tubular epithelial cells. Apoptosis 2015;20:921-929.
[PubMed]
27.
Kim S, Bi X, Czarny-Ratajczak M, Dai J, Welsh DA, Myers L, Welsch MA, Cherry KE, Arnold J, Poon LW, Jazwinski SM: Telomere maintenance genes SIRT1 and XRCC6 impact age-related decline in telomere length but only SIRT1 is associated with human longevity. Biogerontology 2012;13:119-131.
[PubMed]
28.
D'mello NP, Childress AM, Franklin DS, Kale SP, Pinswasdi C, Jazwinski SM: Cloning and characterization of LAG1, a longevity-assurance gene in yeast. J Biol Chem 1994;269:15451-15459.
[PubMed]
29.
Tepper CG, Jayadev S, Liu B, Bielawska A, Wolff R, Yonehara S, Hannun YA, Seldin MF: Role for ceramide as an endogenous mediator of Fas-induced cytotoxicity. Proc Natl Acad Sci USA 1995;92:8443-8447.
[PubMed]
30.
Herget T, Esdar C, Oehrlein SA, Heinrich M, Schütze S, Maelicke A, van Echten-Deckert G: Production of ceramides causes apoptosis during early neural differentiation in vitro. J Biol Chem 2000;275:30344-30354.
[PubMed]
31.
Bose R, Verheij M, Haimovitz-Friedman A, Scotto K, Fuks Z, Kolesnick R: Ceramide synthase mediates daunorubicin-induced apoptosis: an alternative mechanism for generating death signals. Cell 1995;82:405-414.
[PubMed]
32.
Jazwinski SM, Kim S, Dai J, Li L, Bi X, Jiang JC, Arnold J, Batzer MA, Walker JA, Welsh DA, Lefante CM, Volaufova J, Myers L, Su LJ, Hausman DB, Miceli MV, Ravussin E, Poon LW, Cherry KE, Welsch MA; Georgia Centenarian Study and the Louisiana Healthy Aging Study: HRAS1 and LASS1 with APOE are associated with human longevity and healthy aging. Aging Cell 2010;9:698-708.
[PubMed]
33.
Barrett JC: Haploview: visualization and analysis of SNP genotype data. Cold Spring Harb Protoc 2009;2009:pdb.ip71.
[PubMed]
34.
Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265.
[PubMed]
35.
Dipietro L, Caspersen CJ, Ostfeld AM, Nadel ER: A survey for assessing physical activity among older adults. Med Sci Sports Exerc 1993;25:628-642.
[PubMed]
36.
Fillée C, Vranken G, Othmane M, Philippe M, Allaeys JM, Courbe A, Ruelle JL, Peeters R: Results of the recalibration of creatinine measurement with the modular Beckman Coulter Jaffe creatinine method. Clin Chem Lab Med 2011;49:1987-1999.
[PubMed]
37.
Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D: A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999;130:461-470.
[PubMed]
38.
Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF 3rd, Feldman HI, Kusek JW, Eggers P, Van Lente F, Greene T, Coresh J: A new equation to estimate glomerular filtration rate. Ann Intern Med 2009;150:604-612.
[PubMed]
39.
R Development Core Team: R: A Language and Environment for Statistical Computing. Vienna, R Foundation for Statistical Computing, 2014.
40.
Faul F, Erdfelder E, Buchner A, Lang AG: Statistical power analyses using G*Power 3.1: tests for correlation and regression analyses. Behav Res Methods 2009;41:1149-1160.
[PubMed]
41.
Kim S, Jazwinski SM: Quantitative measures of healthy aging and biological age. Healthy Aging Res 2015;4:26.
[PubMed]
42.
Schneider CM, Dennehy CA, Rodearmel SJ, Hayward JR: Effects of physical activity on creatine phosphokinase and the isoenzyme creatine kinase-MB. Ann Emerg Med 1995;25:520-524.
[PubMed]
43.
Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang X, Wang L, Issner R, Coyne M, Ku M, Durham T, Kellis M, Bernstein BE: Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 2011;473:43-49.
[PubMed]
44.
Ward LD, Kellis M: HaploReg: a resource for exploring chromatin states, conservation, and regulatory motif alterations within sets of genetically linked variants. Nucleic Acids Res 2012;40:D930-D934.
[PubMed]
45.
Boulton SJ, Jackson SP: Components of the Ku-dependent non-homologous end-joining pathway are involved in telomeric length maintenance and telomeric silencing. EMBO J 1998;17:1819-1828.
[PubMed]
46.
Reddel RR, Bryan TM, Colgin LM, Perrem KT, Yeager TR: Alternative lengthening of telomeres in human cells. Radiat Res 2001;155:194-200.
[PubMed]
47.
Riha K, Heacock ML, Shippen DE: The role of the nonhomologous end-joining DNA double-strand break repair pathway in telomere biology. Annu Rev Genet 2006;40:237-277.
[PubMed]
48.
Celli GB, Denchi EL, de Lange T: Ku70 stimulates fusion of dysfunctional telomeres yet protects chromosome ends from homologous recombination. Nat Cell Biol 2006;8:885-890.
[PubMed]
49.
Hada M, Kwok RP: Regulation of Ku70-Bax complex in cells. J Cell Death 2014;7:11-13.
[PubMed]
50.
Sawada M, Sun W, Hayes P, Leskov K, Boothman DA, Matsuyama S: Ku70 suppresses the apoptotic translocation of Bax to mitochondria. Nat Cell Biol 2003;5:320-329.
[PubMed]
51.
Meng J, Zhang F, Zhang XT, Zhang T, Li YH, Fan L, Sun Y, Zhang HL, Mei QB: Ku70 is essential for histone deacetylase inhibitor trichostatin A-induced apoptosis. Mol Med Rep 2015;12:581-586.
[PubMed]
52.
Subramanian C, Jarzembowski JA, Opipari AW Jr, Castle VP, Kwok RP: HDAC6 deacetylates Ku70 and regulates Ku70-Bax binding in neuroblastoma. Neoplasia 2011;13:726-734.
[PubMed]
53.
Seluanov A, Danek J, Hause N, Gorbunova V: Changes in the level and distribution of Ku proteins during cellular senescence. DNA Repair (Amst) 2007;6:1740-1748.
[PubMed]
54.
Turpin SM, Lancaster GI, Darby I, Febbraio MA, Watt MJ: Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance. Am J Physiol Endocrinol Metab 2006;291:E1341-E1350.
[PubMed]
55.
Pilane CM, LaBelle EF: NO induced apoptosis of vascular smooth muscle cells accompanied by ceramide increase. J Cell Physiol 2004;199:310-315.
[PubMed]
56.
von Haefen C, Wieder T, Gillissen B, Stärck L, Graupner V, Dörken B, Daniel PT: Ceramide induces mitochondrial activation and apoptosis via a Bax-dependent pathway in human carcinoma cells. Oncogene 2002;21:4009-4019.
[PubMed]
57.
Senkal CE, Ponnusamy S, Rossi MJ, Bialewski J, Sinha D, Jiang JC, Jazwinski SM, Hannun YA, Ogretmen B: Role of human longevity assurance gene 1 and C18-ceramide in chemotherapy-induced cell death in human head and neck squamous cell carcinomas. Mol Cancer Ther 2007;6:712-722.
[PubMed]
58.
Park SY, Lee JH, Kim HY, Yoon KH, Park SK, Chang MS: Differential expression of apoptosis-related factors induces the age-related apoptosis of the gracilis muscle in humans. Int J Mol Med 2014;33:1110-1116.
[PubMed]
59.
Gouspillou G, Sgarioto N, Kapchinsky S, Purves-Smith F, Norris B, Pion CH, Barbat-Artigas S, Lemieux F, Taivassalo T, Morais JA, Aubertin-Leheudre M, Hepple RT: Increased sensitivity to mitochondrial permeability transition and myonuclear translocation of endonuclease G in atrophied muscle of physically active older humans. FASEB J 2014;28:1621-1633.
[PubMed]
60.
Fulle S, Sancilio S, Mancinelli R, Gatta V, Di Pietro R: Dual role of the caspase enzymes in satellite cells from aged and young subjects. Cell Death Dis 2013;4:e955.
[PubMed]
61.
Jiang X, Wang X: Cytochrome c promotes caspase-9 activation by inducing nucleotide binding to Apaf-1. J Biol Chem 2000;275:31199-31203.
[PubMed]
62.
Marzetti E, Lees HA, Manini TM, Buford TW, Aranda JM Jr, Calvani R, Capuani G, Marsiske M, Lott DJ, Vandenborne K, Bernabei R, Pahor M, Leeuwenburgh C, Wohlgemuth SE: Skeletal muscle apoptotic signaling predicts thigh muscle volume and gait speed in community-dwelling older persons: an exploratory study. PLoS One 2012;7:e32829.
[PubMed]
63.
Hazra NC, Dregan A, Jackson S, Gulliford MC: Differences in health at age 100 according to sex: population-based cohort study of centenarians using electronic health records. J Am Geriatr Soc 2015;63:1331-1337.
[PubMed]
64.
Stupka N, Lowther S, Chorneyko K, Bourgeois JM, Hogben C, Tarnopolsky MA: Gender differences in muscle inflammation after eccentric exercise. J Appl Physiol 2000;89:2325-2332.
[PubMed]
65.
Khoury MJ, Evans JP: A public health perspective on a national precision medicine cohort: balancing long-term knowledge generation with early health benefit. JAMA 2015;313:2117-2118.
[PubMed]
66.
Hoenig JM, Heisey DM: The abuse of power. Am Stat 2001;55:19-24.
67.
Goodman SN, Berlin JA: The use of predicted confidence intervals when planning experiments and the misuse of power when interpreting results. Ann Intern Med 1994;121:200-206.
[PubMed]
You do not currently have access to this content.